glp-1 drugs cancer Receptor Agonists: Benefits and Risks in Colorectal Research shows weight-loss drugs may

Effects of Glucagon Like Peptide-1 Receptor Agonists on Endocrine Metabolism Interestingly, GLP-1RAs not only exert a protective effect on the nervous and cardiovascular systems, but also exhibit a regulatory effect on metabolism

These results indicate that GLP-1R activation actively impedes fetal growth

But if someone stays at that starting dose, that would count as microdosing

Possible positive effects that some patients report include: Improved mood and reduced anxiety symptoms potentially linked to successful weight loss and better metabolic control [6] Enhanced self-esteem and body image as weight reduction progresses Reduced food-related anxiety and preoccupation with eating, though evidence for effects on binge eating is limited and observational Better sleep quality in some patients, though this is anecdotal and not well-established in clinical trials These improvements, when they occur, are generally considered secondary to metabolic benefits rather than direct anxiolytic effects

If you take a monoamine oxidase inhibitor drug class (MAOI), you should avoid taking phentermine during MAOI treatment and for 14 days after the last dose

In regards to the current GLP-1 medication shortage, Cutler said this is a topic and a struggle he deals with on a daily basis